Pellagra

Pellagra is a disease associated with a deficiency of niacin (vitamin B3) or tryptophan in the body, which leads to metabolic disorders and a variety of clinical manifestations. The main symptoms of pellagra are dermatitis, diarrhea and dementia, and the disease can also lead to a gloomy and depressive state. This syndrome was first described in the 18th century and is still relevant, especially in regions with low nutrition. Pellagra is more common in countries with a monotonous diet, poor in proteins and vitamins.

History of the disease and interesting historical facts

Pellagra was first described in 1735 by the Italian physician Pietro Malipiero, but a real understanding of its causes began to emerge only in the late 19th century. In 1914, a link was established between the disease and a lack of vitamin B3. Interestingly, pellagra was called the “disease of three Ds” — “dermatitis,” “diarrhea,” and “dementia,” reflecting its leading clinical manifestations. In the early 20th century, outbreaks of pellagra in the United States were associated with poverty and poor nutrition, which is still true today in some developing countries.

Epidemiology

The epidemiology of pellagra depends on several factors, including the nutritional status and socioeconomic status of the population. Before the 19th century, the incidence of pellagra was estimated to be as high as 50 cases per 1,000 people in some countries. In the modern world, although the incidence has decreased, pellagra is still reported, especially in countries with high levels of hunger and vitamin deficiencies. In developing countries, the incidence may be higher, while in developed countries, cases of pellagra are rare and occur mainly in people with mental disorders or alcohol abusers.

Genetic predisposition to this disease

Although pellagra is primarily considered a vitaminosis, there are genetic factors that may contribute to susceptibility to the disease. Research suggests that genes involved in niacin and tryptophan metabolism are involved. The SLC6A20 gene, which encodes a tryptophan transporter, may be associated with the risk of deficiency of this amino acid. However, genetic susceptibility to pellagra remains an area of active research, and the specific mutations responsible for the disease have not been fully identified.

Risk factors for the development of this disease

Risk factors for pellagra can be divided into the following groups:

• Poor nutrition: lack of foods rich in protein and B vitamins in the diet, especially in countries with limited access to a variety of foods.
• Alcoholism: Excessive alcohol consumption can interfere with the absorption of vitamins and lead to niacin deficiency.
• Certain medical conditions: Chronic medical conditions, such as bowel disease, can interfere with the absorption of food.
• Stress and mental disorders: may be associated with changes in diet and deterioration in health.
• Certain medications: Use of isoniazid and other medications may interfere with the metabolism of vitamin B3.

Diagnosis of this disease

Diagnosis of pellagra requires careful clinical examination, as symptoms may be nonspecific. The main symptoms include:

• Dermatitis is characterized by redness and flaking of the skin, especially in areas exposed to sunlight.
• Diarrhea is frequent watery bowel movements.
• Dementia - cognitive impairment, depressive symptoms.

Laboratory tests may include:

• Determination of the level of vitamin B3 in the blood.
• Tryptophan content analysis.
• An assessment of your general health, including blood and urine tests.

Radiological examinations are usually not required but may be used to evaluate comorbidities. Differential diagnosis includes exclusion of other diseases with similar symptoms, such as dermatitis of various etiologies and neurological disorders.

Treatment

Treatment of pellagra is based on nutritional correction and, if necessary, pharmacological support. The main approaches are:

• General treatment is restoration of normal nutrition with an emphasis on foods rich in niacin and tryptophan, such as meat, fish, beans, nuts, and whole grains.
• Pharmacological treatment involves the administration of niacin, usually in doses ranging from 100 to 300 mg per day, depending on the severity of the condition.
• Surgery - In rare cases, surgery may be needed to treat the effects of pellagra, such as skin ulcers.
• Other treatments include psychotherapy for depression and supportive therapy to improve the patient's overall well-being.

List of medications used to treat this disease

Among the drugs most commonly used to treat pellagra are:

• Niacin (nicotinic acid) is the main drug for correcting vitamin B3 deficiency.
• Tryptophan is an amino acid that promotes the synthesis of niacin in the body.
• Multivitamin complexes - for general improvement of health and replenishment of other vitamins.

Disease monitoring

Monitoring of patients with pellagra includes regular observation of their condition, evaluation of the effectiveness of treatment, and identification of possible complications. The prognosis with timely treatment is usually positive, but advanced cases of pellagra can lead to serious consequences, including persistent neurological disorders and even death.

Age-related features of the disease

Pellagra can develop at any age, but age-related features include:

• In children and adolescents, the disease is more often associated with malnutrition and can lead to delayed growth and development.
• In adults, pellagra can be caused by alcoholism and stress.
• In older adults, the risk of developing pellagra may be increased by underlying medical conditions and a lack of varied diet.

Questions and Answers

• What is pellagra? Pellagra is a disease caused by vitamin B3 deficiency, characterized by dermatitis, diarrhea and dementia.
• What are the main symptoms of pellagra? The main symptoms include skin manifestations, bowel disorders and cognitive impairment.
• How is pellagra treated? Pellagra is treated with dietary modifications and niacin to restore vitamin B3 levels in the body.
• Who is at risk for developing pellagra? Those at risk include people with malnutrition, alcohol abusers, and patients with chronic diseases.
• What is the prognosis for patients with pellagra? With timely treatment, the prognosis is positive in most cases, although advanced forms can lead to serious complications.